Previous Article | Next Article ![]()
Journal of Bacteriology, November 1999, p. 6656-6663, Vol. 181, No. 21
Bioprocess Engineering Division,
Received 3 May 1999/Accepted 12 August 1999
In order to study the physiological role of acetate metabolism in
Escherichia coli, the growth characteristics of an E. coli W3100 pta mutant defective in
phosphotransacetylase, the first enzyme of the acetate pathway, were
investigated. The pta mutant grown on glucose minimal
medium excreted unusual by-products such as pyruvate,
D-lactate, and L-glutamate instead of acetate.
In an analysis of the sequential consumption of amino acids by the pta mutant growing in tryptone broth (TB), a brief lag
between the consumption of amino acids normally consumed was observed, but no such lag occurred for the wild-type strain. The pta
mutant was found to grow slowly on glucose, TB, or pyruvate, but it
grew normally on glycerol or succinate. The defective growth and
starvation survival of the pta mutant were restored by the
introduction of poly-
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Acetate Metabolism in a pta Mutant of
Escherichia coli W3110: Importance of Maintaining Acetyl
Coenzyme A Flux for Growth and Survival

-hydroxybutyrate (PHB) synthesis genes
(phbCAB) from Alcaligenes eutrophus, indicating
that the growth defect of the pta mutant was due to a
perturbation of acetyl coenzyme A (CoA) flux. By the stoichiometric
analysis of the metabolic fluxes of the central metabolism, it was
found that the amount of pyruvate generated from glucose transport by
the phosphoenolpyruvate-dependent phosphotransferase system (PTS)
exceeded the required amount of precursor metabolites downstream of
pyruvate for biomass synthesis. These results suggest that E. coli excretes acetate due to the pyruvate flux from PTS and that
any method which alleviates the oversupply of acetyl CoA would restore
normal growth to the pta mutant.
*
Corresponding author. Mailing address: Bioprocess
Engineering Division, Korea Research Institute of Bioscience and
Biotechnology (KRIBB), P.O. Box 115, Yusong, Taejon 305-600, Korea.
Phone: 82-42-860-4483. Fax: 82-42-860-4594. E-mail:
jgpan{at}kribb4680.kribb.re.kr.
Present address: Center for Vaccine Development, School of
Medicine, University of Maryland, Baltimore, MD 21201.
This article has been cited by other articles:
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |